Van Cangh PJ - Search Results

1

Does site-specific labelling and individual processing of sextant biopsies improve the accuracy of prostate biopsy in predicting pathological stage in patients with T1c prostate cancer?

Tombal B, Tajeddine N, Cosyns JP, Feyaerts A, Opsomer R, Wese FX, Van Cangh PJ. Tombal B, et al. Among authors: van cangh pj. BJU Int. 2002 Apr;89(6):543-8. doi: 10.1046/j.1464-410x.2002.02672.x. BJU Int. 2002. PMID: 11942961

2

Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy.

Tombal B, Querton M, de Nayer P, Sauvage P, Cosyns JP, Feyaerts A, Opsomer R, Wese FX, Van Cangh PJ. Tombal B, et al. Among authors: van cangh pj. Urology. 2002 Feb;59(2):256-60. doi: 10.1016/s0090-4295(01)01515-1. Urology. 2002. PMID: 11834398

3

[Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].

Feyaerts A, Stainier L, Nollevaux MC, De Groote P, Lorge F, Opsomer R, Wese FX, Cosyns JP, Van Cangh P. Feyaerts A, et al. Acta Urol Belg. 1998 Mar;66(1):1-6. Acta Urol Belg. 1998. PMID: 9611351 French.

4

Undetectable prostate-specific antigen in aging men.

Abi-Aad AS, Opsomer RJ, Wese FX, Lorge F, Van Cangh PJ. Abi-Aad AS, et al. Among authors: van cangh pj. Urology. 1994 Mar;43(3):394-6. doi: 10.1016/0090-4295(94)90088-4. Urology. 1994. PMID: 7510914

5

[PSA and anatomopathological stage of prostatic cancer].

Chatzopoulos C, Uystepruyst P, Hermans B, Wese FX, Opsomer R, Abi Aad A, Lorge F, Van Cangh PJ. Chatzopoulos C, et al. Among authors: van cangh pj. Acta Urol Belg. 1995 Mar;63(1):97-102. Acta Urol Belg. 1995. PMID: 7537014 French.

6

Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.

Van Cangh PJ, De Nayer P, Sauvage P, Tombal B, Elsen M, Lorge F, Opsomer R, Wese FX. Van Cangh PJ, et al. Prostate Suppl. 1996;7:30-4. Prostate Suppl. 1996. PMID: 8950361

7

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA.

Van Cangh PJ, De Nayer P, De Vischer L, Sauvage P, Tombal B, Lorge F, Wese FX, Opsomer R. Van Cangh PJ, et al. Urology. 1996 Dec;48(6A Suppl):67-70. doi: 10.1016/s0090-4295(96)00613-9. Urology. 1996. PMID: 8973703

8

[Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].

Feyaerts A, Delrée A, Lorge F, Opsomer RJ, Wese FX, Van Cangh PJ, Draguet AP, Cosyns JP. Feyaerts A, et al. Among authors: van cangh pj. Acta Urol Belg. 1997 Mar;65(1):11-8. Acta Urol Belg. 1997. PMID: 9245198 French.

9

Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.

Tombal B, De Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, Van Cangh PJ. Tombal B, et al. Among authors: van cangh pj. BJU Int. 1999 Dec;84(9):1015-20. doi: 10.1046/j.1464-410x.1999.00386.x. BJU Int. 1999. PMID: 10571626

10

Immediate vs. delayed androgen deprivation for prostate cancer.

Van Cangh PJ, Gala JL, Tombal B. Van Cangh PJ, et al. Prostate Suppl. 2000;10:19-25. doi: 10.1002/1097-0045(2000)45:10+<19::aid-pros5>3.0.co;2-#. Prostate Suppl. 2000. PMID: 11056489 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters